𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Specificity of mutations in the PMS2-deficient human tumor cell line HEC-1-A

✍ Scribed by Takesi Kato; Fumio Yatagai; Barry W. Glickman; Akira Tachibana; Mituo Ikenaga

Book ID
114072427
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
156 KB
Volume
422
Category
Article
ISSN
0027-5107

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Specific killing of P53 mutated tumor ce
Specific killing of P53 mutated tumor cell lines by a cross-reactive human HLA-A2-restricted P53-specific CTL line
✍ Peter A. WΓΌrtzen; Lars Ø. Pedersen; Hans S. Poulsen; Mogens H. Claesson πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 144 KB

p53 is upregulated in the majority of spontaneous tumors and the HLA class I molecule HLA-A2 is expressed by approximately 50% of the caucasians. Potentially, these facts make HLA-A2-binding p53 peptides for CTL-inducing immunotherapy applicable to a broad range of cancer patients. In our study, we

Tumor-suppressive activity of the growth
Tumor-suppressive activity of the growth arrest-specific gene GAS1 in human tumor cell lines
✍ Andreas Evdokiou; Prudence A. Cowled πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 261 KB πŸ‘ 2 views

The GAS1 gene product induces growth arrest through a p53-dependent mechanism. To investigate whether GAS1 is a tumor suppressor gene, we transfected GAS1-negative human tumor cells with GAS1 plasmids and analyzed growth characteristics of stable transfectants. When a constitutively expressing GAS1